Grants for Public and State controlled institutions of higher education - Health

This funding opportunity supports multi-site clinical trials for innovative treatments and interventions aimed at preventing or alleviating symptoms of Alzheimer's disease and related dementias, inviting applications from a diverse range of organizations and institutions.

This funding opportunity supports innovative research projects aimed at developing tools and treatments for diagnosing and mitigating injuries from radiation exposure during public health emergencies.

This funding opportunity announcement (FOA) encourages innovative research to develop, characterize, and improve animal models, biological materials, and novel technologies to better understand human health and disease. This FOA also seeks projects aimed at improving the diagnosis and control of diseases that interfere with animal use for biomedical research. The proposed project must have broad application to multiple NIH Institutes or Centers (ICs) to align with the Office of Research Infrastructure Programs (ORIP) trans-NIH mission. The proposed studies must explore multiple body systems or evaluate diseases that impact multiple body systems. Applications that develop models focused on a specific disease or area of research, or only propose studies primarily relevant to a single NIH IC will be considered not acceptable to this FOA.

This funding opportunity supports early-career clinical researchers in the U.S. to develop expertise in implementation science for substance use prevention and treatment through mentored clinical trials addressing the overdose crisis.

The "Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dementias (ADRD)" grant aims to fund the creation and testing of new, complex human cell models that accurately represent Alzheimer's and related dementias, with the goal of improving our understanding of these diseases and aiding in the development of potential therapies.

This grant provides funding for educational programs that improve the skills and knowledge of researchers analyzing large, complex datasets related to brain function, behavior, and social factors affecting health outcomes.

This funding opportunity supports innovative, time-sensitive research projects that enhance ongoing clinical studies related to arthritis, musculoskeletal, and skin diseases by leveraging existing patient data and samples.

This funding opportunity supports research that develops innovative tools to measure and enhance children's language development, particularly by engaging diverse communities and understanding environmental influences.

This funding opportunity supports community-based organizations in the Mid-Atlantic region to implement sustainable forestry initiatives that promote environmental justice, improve public health, and create green job opportunities in disadvantaged areas.

This funding opportunity provides financial support for researchers developing innovative, non-opioid treatments for various types of pain, with a focus on early-stage studies and collaboration with underrepresented populations.

Grant Title: New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed) aims to fund innovative research to develop new treatments for genital herpes that can reduce viral shedding, prevent lesions, and lower transmission risks.

This funding opportunity supports early-stage research projects aimed at discovering new pain management targets within specific proteins, encouraging innovative approaches to develop non-addictive therapies for pain relief.

This funding opportunity supports research centers focused on developing innovative contraceptive methods, particularly non-hormonal options, and encourages participation from diverse institutions and underrepresented groups.

The "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services" grant aims to fund research that develops and tests new strategies for combining primary care, HIV, Hepatitis, and substance use disorder prevention and treatment services to improve health outcomes for individuals at high risk for or living with these conditions in the US.

This funding opportunity supports researchers in conducting early-stage clinical trials for innovative treatments and interventions targeting neurological disorders.

This funding opportunity provides financial support for early-stage researchers from diverse backgrounds to conduct independent studies on communication disorders, including hearing and speech issues, with a focus on addressing significant scientific and clinical challenges.

This funding opportunity provides financial support to organizations working with the Eswatini government to strengthen public health systems for monitoring and responding to HIV, TB, and related health threats.

This funding opportunity is designed to support research initiatives that will study and track the long-term effects of severe viral respiratory infections in young children, aiming to improve their health outcomes as they grow.

This funding opportunity supports researchers in developing small molecule chemical probes to investigate biological processes related to mental health, aging, drug addiction, and eye diseases.

The purpose of this initiative is to: 1.Support mining of SCORCH data to identify cell types, transcripts, enhancers, or transcriptional networks that play a role in HIV/ART or SUD molecular responses 2.Support functional validation studies (e.g. epigenomic or transcriptomic manipulation, high throughput secondary screening, etc.) to confirm or deny a biological role for data-mined cell types, transcripts, enhancers, or transcriptional networks in HIV/ART or SUD molecular responses 3.Provide foundational knowledge for understanding SUD and/or HIV/ART molecular mechanisms and to generate validated targets that could serve as a foundation for new SUD or HIV therapeutics (including NeuroHIV cognitive phenotypes)